Pharmidex's new service offering Medical Device Testing!

June 16, 2025

👉 www.pharmidex.com/medical-device-testing-services

With over 23 years of experience in preclinical R&D, we’re expanding our capabilities to support the development and regulatory testing of innovative medical devices from biocompatibility assessments to in vitro and in vivo efficacy models.

This new service allows us to collaborate even more closely with biotech companies, CRO partners, academic innovators and medical device startups helping bring safe, effective and transformative technologies to patients faster.

Whether you're exploring a novel implant, delivery system, or diagnostic platform, our team is ready to support you at every step with the same scientific integrity and agility that Pharmidex is known for.

💡 Let’s accelerate innovation, together.

#MedicalDevices #Pharmidex #DrugDevelopment #MedicalDeviceTesting #Biotech #ScientificInnovation #RegulatorySupport #LifeSciences

< Older Post

Newer Post >

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist

July 30, 2025

We’re Hiring! Senior/Principal Scientist–In Vivo Pharmacologist

🎓 Welcoming Future Scientists to Pharmidex! 🎓

July 28, 2025

We’re delighted to welcome Gabrielle Georgiou and Dr. Mohammed Ahmad from the University of Hertfordshire as they begin their first experience in a scientific CRO environment here at Pharmidex ! This partnership is an exciting step in fostering early-career scientific talent by offering hands-on exposure to real-world drug discovery and preclinical research. A big thank you to the University of Hertfordshire for partnering with us to support the next generation of innovators. We’re proud to play a role in shaping future leaders in science through meaningful, practical learning opportunities. 👩‍🔬 👨‍🔬 Welcome to the team, Gabrielle and Mohammed!

Does your compound taste good enough for the clinic?

July 24, 2025

At Pharmidex , we offer Brief Access Taste Aversion (BATA) testing, which is a behavioural assay that quantifies how test subjects respond to different compounds or formulations by measuring lick response and aversion. This helps identify: ✅ Bitter-tasting APIs ✅ Unpalatable excipients ✅ The success of taste-masking strategies ✅ Formulation-dependent compliance risks Get in touch if you’re developing oral formulations, paediatric drugs, or repurposing bitter APIs, this could be the data your IND package needs.